Criterium Inc.
Criterium, Inc. is a full-service contract research organization dedicated to providing efficiency and expertise in clinical trial services worldwide. Established in 1991, it leverages state-of-the-art technologies such as IVR, EDC, IWR, ePRO, and eCOA to connect stakeholders to real-time data sources, ensuring cost-effectiveness, adherence to timelines, and high-quality data. The company has expanded globally into markets including Canada, India, South Africa, and partnerships across the EU, Russia, Australia, and New Zealand. It specializes in oncology research consortia and offers a broad range of clinical trial services, including project management, data management, monitoring, site selection, regulatory, biostatistics, medical writing, IVR/IWR services, pharmacovigilance, and trial rescue services.
Industries
Nr. of Employees
medium (51-250)
Criterium Inc.
Products
IVR/IWR
Interactive Voice Response (IVR), Web-Board Reporting (IWR/IRT), and electronic Patient Reported Outcomes (ePRO) systems that interface seamlessly with EDC for comprehensive clinical study management, data collection, and real-time reporting.
Full Service Research
Comprehensive clinical research services spanning Phase I through Phase IV, registration, launch, and post-marketing studies.
Academic Thoracic Oncology Medical Investigators Consortium
An innovative and focused full-service clinical research model and consortium created to enhance the state of care for thoracic and lung cancer patients by expediting clinical trials and identifying new targeted drugs.
GI Cancer Consortium
Providing expertise and innovative solutions for the rapid design, implementation, management and completion of complex GI cancer trials.
Academic GI Cancer Consortium (AGICC)
An innovative research model bringing together a world class team of institutions and investigators to design and rapidly complete clinical trials in gastrointestinal cancers.
Breast Cancer Consortium
An innovative research model that has brought together an expert team of institutions and investigators to design clinical trials in breast cancer.
IVR/IWR
Interactive Voice Response (IVR), Web-Board Reporting (IWR/IRT), and electronic Patient Reported Outcomes (ePRO) systems that interface seamlessly with EDC for comprehensive clinical study management, data collection, and real-time reporting.
Full Service Research
Comprehensive clinical research services spanning Phase I through Phase IV, registration, launch, and post-marketing studies.
Academic Thoracic Oncology Medical Investigators Consortium
An innovative and focused full-service clinical research model and consortium created to enhance the state of care for thoracic and lung cancer patients by expediting clinical trials and identifying new targeted drugs.
GI Cancer Consortium
Providing expertise and innovative solutions for the rapid design, implementation, management and completion of complex GI cancer trials.
Academic GI Cancer Consortium (AGICC)
An innovative research model bringing together a world class team of institutions and investigators to design and rapidly complete clinical trials in gastrointestinal cancers.
Breast Cancer Consortium
An innovative research model that has brought together an expert team of institutions and investigators to design clinical trials in breast cancer.
Services
Full-service clinical development support from study design through final clinical report, including project management, monitoring, and study oversight.
Study-level project management and coordination of cross-functional activities to maintain timelines and deliverables.
Clinical data management including EDC setup, real-time data capture, and data cleaning workflows.
On-site and remote monitoring services performed to ICH-GCP standards, including clinical and medical monitoring.
Identification and activation of clinical sites, including registration forms and site qualification processes.
Regulatory affairs assistance, audit readiness and preparation of regulatory documentation.
Full-service clinical development support from study design through final clinical report, including project management, monitoring, and study oversight.
Study-level project management and coordination of cross-functional activities to maintain timelines and deliverables.
Clinical data management including EDC setup, real-time data capture, and data cleaning workflows.
On-site and remote monitoring services performed to ICH-GCP standards, including clinical and medical monitoring.
Identification and activation of clinical sites, including registration forms and site qualification processes.
Regulatory affairs assistance, audit readiness and preparation of regulatory documentation.
Expertise Areas
- Clinical trial management
- EDC and clinical data systems
- Biostatistics and statistical reporting
- Regulatory compliance and quality assurance
Key Technologies
- Electronic data capture (EDC)
- Interactive response technology (IVR/IWR/IRT)
- ePRO / eCOA platforms
- Real-time clinical data integration platforms
News & Updates
The Oncology Consortia of Criterium held their annual Investigator Meetings at the 2025 ASCO Annual Meeting, fostering collaboration among experts to advance cancer research.
Discover the latest advancements in skin cancer prevention, diagnosis, and treatment.
Exploring innovative personalized medicine strategies in clinical research.
Insights into recent clinical research providing new treatment options for autism spectrum disorder.
Emerging clinical research developments in men's health.
Recent advances and ongoing research in PTSD treatment.
The Oncology Consortia of Criterium held their annual Investigator Meetings at the 2025 ASCO Annual Meeting, fostering collaboration among experts to advance cancer research.
Discover the latest advancements in skin cancer prevention, diagnosis, and treatment.
Exploring innovative personalized medicine strategies in clinical research.
Insights into recent clinical research providing new treatment options for autism spectrum disorder.
Emerging clinical research developments in men's health.
Recent advances and ongoing research in PTSD treatment.